Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 23 July 2019. Amy Klobuchar.

Executive Summary

Speaking to reporters at the National Press Club in Washington, DC, Democratic presidential candidate US Sen. Amy Klobuchar downplayed the need for action on repealing the 2.3% medical device tax as part of her “100 Days Plan” if she were to win the presidency. Check out the senator's comments here.

"I don't think I would take any kind of action in the first hundred days, but I continue to believe it should be suspended, that it should be repealed, and I think that it could actually be done even before I become president." – US Sen. Amy Klobuchar, D-Minnesota

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel